Immuneel Therapeutics Launches Affordable CAR T-Cell Therapy for Blood Cancer in India Qartemi Offers New Hope for B-Cell Non-Hodgkin Lymphoma Patients at a Fraction of Global Costs Immuneel Therapeutics, a Bengaluru-based cell and gene therapy company co-founded by Kiran Mazumdar-Shaw, has announced the launch of Qartemi, India's
ENDPOINTS-11 BIOPHARMA’S MOST PROMISING STARTUPS 2023’ INDIA – At the Endpoints News Awards in Boston, USA, Immuneel Therapeutics, India’s leading clinical-stage cell and gene therapy startup, was named and awarded amongst 'Endpoint-11 Biopharma’s Most Promising Startups 2023'. The event annually honours the top 11 global biopharma
